Kaempferia parviflora, a plant used in traditional medicine to enhance sexual performance contains large amounts of low affinity PDE5 inhibitors

Temkitthawon, Prapapan; Hinds, Thomas R. ; Beavo, Joseph A.; Viyoch, Jarupa; Suwanborirux, Khanit; Pongamornkul, Wittaya; Sawasdee, Pattara; Ingkaninan, Kornkanok

Abstract

Aim of the study

A number of medicinal plants are used in traditional medicine to treat erectile dysfunction. Since cyclic nucleotide PDEs inhibitors underlie several current treatments for this condition, we sought to show whether these plants might contain substantial amounts of PDE5 inhibitors.

Materials and methods

Forty one plant extracts and eight 7-methoxyflavones from Kaempferia parviflora Wall. ex Baker were screened for PDE5 and PDE6 inhibitory activities using the two-step radioactive assay. The PDE5 and PDE6 were prepared from mice lung and chicken retinas, respectively. All plant extracts were tested at 50 µg/ml whereas the pure compounds were tested at 10 µM.

Results

From forty one plant extracts tested, four showed the PDE5 inhibitory effect. The chemical constituents isolated from rhizomes of Kaempferia parviflora were further investigated on inhibitory activity against PDE5 and PDE6. The results showed that 7-methoxyflavones from this plant showed inhibition toward both enzymes. The most potent PDE5 inhibitor was 5,7-dimethoxyflavone (IC50 = 10.64 ± 2.09 µM, selectivity on PDE5 over PDE6 = 3.71). Structure activity relationship showed that the methoxyl group at C-5 position of 7-methoxyflavones was necessary for PDE5 inhibition.

Conclusions

Kaempferia parviflora rhizome extract and its 7-methoxyflavone constituents had moderate inhibitory activity against PDE5. This finding provides an explanation for enhancing sexual performance in the traditional use of Kaempferia parviflora. Moreover, 5,7-dimethoxyflavones should make a useful lead compound to further develop clinically efficacious PDE5 inhibitors.

References:

Corbin, Jackie D; Francis, Sharron H; Webb, David J (2002) Phosphodiesterase type 5 as a pharmacologic target in erectile dysfunction. Urology. Volume 60, Issue 2, Supplement 2, August 2002, Pages 4-11. https://doi.org/10.1016/S0090-4295(02)01686-2

Essayan, D.M. (1999) Cyclic nucleotide phosphodiesterase (PDE) inhibitors and immunomodulation. Biochemical Pharmacology Volume 57, Issue 9, 1 May 1999, Pages 965-973. https://doi.org/10.1016/S0006-2952(98)00331-1

Ko, Wun-Chang; Shih, Chwen-Ming; Lai, Ya-Hsin; Chen, Jun-Hao; Huang, Hui-Lin (2004) Inhibitory effects of flavonoids on phosphodiesterase isozymes from guinea pig and their structure activity relationships. Biochemical Pharmacology Volume 68, Issue 10, 15 November 2004, Pages 2087-2094. https://doi.org/10.1016/j.bcp.2004.06.030

Shin, Hye Joo; Ja Kim, Hyoung; Kwak,Jong Hwan; Chun, Hyung Ok; Kim, Je Hak Park, Hokoon; Kim, Dong Hyun; Lee, Yong Sup (2002) A prenylated flavonol, sophoflavescenol: a potent and selective inhibitor of cGMP phosphodiesterase 5. Bioorganic & Medicinal Chemistry Letters Volume 12, Issue 17, 2 September 2002, Pages 2313-2316. https://doi.org/10.1016/S0960-894X(02)00401-8

Sonnenburg, William K.; Rybalkin, Sergei D.; Bornfeldt, Karin E.; Kwak, Keith S.; Rybalkina, Irina G.; Beavo, Joseph A. (1998) Identification, quantitation, and cellular localization of PDE1 calmodulin-stimulated cyclic nucleotide phosphodiesterases. Methods Volume 14, Issue 1, January 1998, Pages 3-19. https://doi.org/10.1006/meth.1997.0561

Sutthanut, K.; Sripanidkulchai, B.; Yenjai, C. ; Jay, M. (2007) Simultaneous identification and quantitation of 11 flavoid constituents in Kaempferia parviflora by gas chromatography. Journal of Chromatography A Volume 1143, Issues 1–2, 2 March 2007, Pages 227-233